Week 1 Flashcards
Pharmacogenetics
the area of biochemical genetics concerned with the impact of genetic variation on drug response and metabolism
What are the two major physiological responses to drugs?
1) achieving desired effect
2) removing/inactivating the drug
Pharmokinetics
rate at which the body absorbs, transports, metabolizes, and excretes drug
ATME
“whether/how much drug reaches target”
Pharmakodynamics
response of drug binding to its target and downstream targets
“what happens when drug reaches target”
Phase I drug metabolism
attach polar group onto compound to make more soluble - hydroxylation step
Phase II drug metabolism
attach sugar/acetyl group to detoxify drug and make it easier to excrete
Cytocrome P450
CYP450
responsible for phase I metabolism
Most are associated with inactivation of drug, but CYP2D6 is associated with activation
CYP2D6
drug necessary to convert codeine into morphine
Frameshift mutation in CYP2D6
non function - no conversion to morphine
Splicing of CYP2D6
skin exons or alter reading frame - non functional - no conversion to morphine
Missence of CYP2D6
alter protein function - reduced activity - less conversion of morphine
Copy number alleles in CYP2D6
increased gene copies is increased activity!
Poor, Normal, or ultrarapid/ultrafast
CYP3A
Cyclosporine
Inhibitors: ketoconazole, grapefruit juice
Activators: rifampicin
CYP2D6
Codein, tricyclic, antidepressants
CYP2C9
warfarin
TMPT
6-mercaptopurine
6-thioguanine
Chemotherapeutic, but bone marrow toxicity
ranges from high to virtually indetectaable enzymatic activity. Those with low (1:400) have extreme bone marrow suppression that causes fatality if not dosed correctly.
must give 1/10 of standard dose for those patients.
G6PD
Sulfonamide, dapsone
X-linked enzyme
susceptible to hymolytic anemia after drug exposure.
VKORC1
Warfarin
blood thinner
Warfarin
Both a CYP2C9 and VKORC1
Anti-coagulant
prescribed at standard dose of 5 mg and pt is watched over next few moths for excessive bleeding or clotting and dose id adjusted.
NAT
isoniazid for TB
if quickly digested: no liver problems but not adequate TB treatment
if slowly digested: good TB treatment, but liver problems.
Haplotype
a group of allele sin coupling at closely linked loci, usually inherited as a unit
Pleitropic
multiple phenotypic effects due to a mutation(S) in a single gene. Often used when phenotypes are seemingly unrelated and/or in different tissues.
Incomplete dominance
phenotype is intermediate between two homozygous phenotypes
trait inherited in dominant manner, but is more severe in homozygous than heterozygote.
semidominant
1st law of segregation
At meiosis, alleles separate (or segregate) from each other such that each gamete (egg or sperm) receives one copy from each allele pair.
have a 50:50 chance of getting the gene
Mende’s 2nd law of independent assortment
At meiosis, the segregation of each pair of alleles is independent. [Note: genes physically near each other
(‘linked’) on the same chromosome violate this law]
Co-dominant traits
if both alleles/traits are expressed in heterozygous state
Hemizygous
male with mutated X
X-Inacivation
one chromosome is largely inactivated in somatic cells, to equalize expression of X-linked Genes between sexes.
Penetrance
fraction of individuals with a trait genotype who manifest the disease
Can be either 100% penetrant or Incomplete penetrance.
Analogous to light switch
Expressivity
degree to which a trait is expressed (measure of severity)
analogous to dimmer
influenced by sex, environmental factors, stochastic events, and modifier genes
Phenocopies
Diseases that are due to non-genetic factors
ie. thyroid cancer due to radiation exposure vs. thyroid cancer due to RET mutation
Four factors that influence allele frequency
1) natural selection
2) genetic drift
3) nutation
4) gene flow
Genome mutation
Due to chromosome missegregation
2-4 x 10^-2/cell division
Chromosome mutation
due to chromosome rearrangement
6x10^-4 / cell division
Gene mutation
due to base pair mutation
10^-5 to 10^-6
Polymorphism
genetic mutations that is common in more than 1% of the population
Genetic Drift
random fluctuation of allele frequencies, usually in small populations
Gene Flow
when populations with different allele frequencies mix
Incidence rate of autusomal domiant
2* mutation rate
Assumptions of Hardy-Weingberg
Large populations are randomly mating
Allele frequency remains constant because
1) there are no new mutations
2) no selection for/against alleles
3) no immigration/emigration with new allele frequencies
Stratification
populations containing two or more subgroups preferentially mate within own subgroup
(AA) with sickle cell anemia
Assortive Mating
Choice of mate is dependent on particular trait (ie height, intelligence, dwarfism, blindness)
Mitosis vs. Meiosis
1) paternally and maternally derived homologous chromosomes pair at onset of meiosis, where as they segregate independently in mitosis
2) reciprocal recombination events occur in meiosis, but are rare in mitosis
chiasmata
crossing of chromatid strands of homologous chromosomes
a physical linkage
Bivalent
pair of homologous chromosomes in association, as seen in metaphase of first meiotic division
Synaptonemal complex
The synaptonemal complex is a protein structure that forms between homologous chromosomes (two pairs of sister chromatids) during meiosis and is thought to mediate chromosome pairing, synapsis, and recombination.
Disassembled during end of prophase.
Reciprocal Recombination
generate physical linkages between homologs
2-3 crossover events occur per pari of chromosomes
Genetic consequences of meiosis
1) reduction of chromosome number
2) recombination during meiosis I prophase giving 2^23 possibilities
3) independent assortment of maternal and paternal chromosomes
Non-disjunction in meiosis I
100% abnormal cells
2 (N+1) and 2(N-1)
Non-disjunction in Meiosis II
50% abnormal cells
2 N and 1 (N+1) and 1(N-1)
What increases rates of non-disjunction?
1) Maternal Age
2) crossing over events that occur too near (entanglement) or too far from centromere (less effective in spindle attachments)
3) Reduction of recombination events
what percentage of genetic abnormalities cause first semester spontaneous abortions?
50%
what percentage of live born infants have congenital abnormalities?
3%
What percentage of sperm is abnormal?
1-3%
What percentage of ova are abnormal?
> 3%
increasing with advanced maternal age
metacentric
central centromere
submetacentric
off center and arms are clearly of different lengths
Acentric
centromere nearly at the end
includes 13, 14, 15, 21, 22
small masses of chromatin called Satellites
Satellites
a small mass of chromosome containing genes for rRNA at the end of the short arm of acentric chromosomes
Highly polymorphic and variable
Telocentric
centromere at one end and only a single arm
not observed in humans
ploidy
number of homologous chromosome sets present in a cell or organism
Euploidy
true ploidy
full sets of chromosomes
Triploid
3 sets of chromosomes - 69
Tetraploid
4 sets of chromosomes - 92
mechanism that causes tetraploidy
DNA duplication but not cell division (endomitosis)
Aneuploidy
abnormal chromosome number due to the extra or missing chromosome
arrises during meiosis I or II, could be paternal or maternal
or post zygotically
Tolerated aneuploidies at conception
45,X
Trisomy 16, 21, 22
Tolerated aneuploidies at live birth
trisomy 13, 18, 21
sex chromosome aneuploidy
When should cytogenic studies be ordered?
1) multiple congenital abnormalities
2) developmental delay + minor abnormalities
3) historical familial chromosomal abnormality
4) intrauterine growth reduction
5) history of miscarriages
Postnatal cytogenic studies
peripheral blood
skin biopsy
Cytogenic Studies with acquired cancer
Bone Marrow
tumor
peripheral blood
lymph node
Trisomy 21 Phenotype:
1) brachycephaly (shorter head) 2) midface hypoplasia 3) up slanting palpebral fissures 4) spicanthal folds (extra skin on inside of eyes) 5) small ears 6) large appearing tongue 7) increased joint mobility 8) brushfield spots 9) incurving 5th finger 10) increased space between 1st and 2nd toe 11) horizontal fissure
Clinical Features of Down Syndrome: cardiac
50% have congenital heart defect
mostly atrioventricular canal
GI defects in Down Syndrome
10-15% of DS babies
esophageal or duodenal atresias
Hirshprungs disease
non anatomical defects: feeding problems, gastro esophageal reflux disease, celiac
How are esophageal and duodenal atresias detected
extra amniotic fluid becuase baby can’t swallow
called polyhydramnios
Ophthalmologic problems in Down Syndrome
60% of DS patients have there
1) conjuntivitis (blocked tear ducts) 2) myoptia (near sightedness) 3) lazy eye 4) nysagmus (jiggly eye) 5) cataracts
Ear, nose and throat problems in Down Syndrome
Chronic ear infections
deafness (both sensorineural and conductive)
chronic nasal congestion
enlarged tonsil and adenoids leading to sleep apnea
Percentage of hearing loss in Down Syndrome
75%
Endocrine disorders in Down Syndrome
25% Thyroid Disease (hypothyroidism) Insulin dependent diabetes Alopecia Reduced fertility (normal puberty) females can be fertile, but males are almost never
Orthopedic problems in Down Syndrome
Hips and joint subluxation
Atlantoaxial subluxation
Blood issues in Down Syndrome
Myeloproliferation disorder
Increase risk of leukemia (12-20X) in perinatal period
iron deficiency due to feeding issues
Neurological/Psychiatric problems in down Syndrome
Hypotonic Seizures (infantile spasms) Depression Early onset AD autism (1/10)
Development and behavioral phenotype of Down Syndrome
Delayed gross motor development due to hypotonia
Intellectual disability IQ -50
Speech problems due to small mouth/large tongue
Recurrence risk of Down Syndrome
1/100 + risk of maternal age